The top healthtech and medtech startups in Israel in 2026 are Aidoc (clinical AI, raised $150 million this year), TytoCare (remote medical exams), Insightec (focused ultrasound), MeMed (bacterial vs. viral diagnostics) and Sensi.AI (AI home care for seniors). Medical AI is the fastest-growing segment. Ten, below.
Israel's health tech sector benefits from something few countries have: four health maintenance organizations (HMOs) holding decades of digitized records for almost the whole population, plus hospitals like Sheba and Rambam that run their own innovation arms. That has made the country a testing ground for medical AI, alongside a long tradition of medical devices. 2026 saw big exits, including Medtronic's purchase of CathWorks and Olympus's deal for BioProtect, so this list focuses on the companies still independent as of October 2026.
Israel's medical AI leader, flagging urgent findings in scans before a radiologist opens them.
Aidoc's AI reviews CT and other imaging as it is taken and alerts care teams to critical findings such as brain bleeds and pulmonary embolisms, then coordinates the follow-up. It has expanded from radiology into a broader clinical AI platform for hospitals.
It raised $150 million in April 2026, one of the largest medical AI rounds of the year anywhere.
A handheld device that lets a doctor examine you from a distance.
TytoCare's device lets patients or nurses capture heart and lung sounds, ear and throat images and temperature at home, school or work, and share them with a clinician in a telehealth visit. Health systems and insurers deploy it to keep patients out of emergency rooms.
It is one of the most widely used Israeli digital health products in the US.
Treats tremor by focusing ultrasound inside the brain, with no incision.
Insightec's Exablate system uses MRI-guided focused ultrasound to treat essential tremor and tremor-dominant Parkinson's disease without surgery, and is being studied for other neurological uses.
Founded in 1999, it is valued at over $1 billion and is one of the most significant Israeli medical device companies.
Tells doctors in minutes whether an infection is bacterial or viral.
MeMed BV reads the immune system's response to infection rather than looking for the pathogen, helping clinicians decide quickly whether antibiotics are needed. That tackles both overprescription and missed bacterial infections.
It runs on MeMed's own rapid analyzer in emergency departments and has FDA clearance.
Listens for changes in an older person's wellbeing at home, without cameras.
Sensi.AI uses audio-based AI in the home to detect signs of health and behavioral change in seniors, and gives home care agencies insights to act on. It sits in the growing agetech category.
It has raised about $100 million, including a $45 million Series C, and is on Forbes Israel's 2026 list of next billion-dollar startups.
Prepares a doctor for each visit by summarizing the patient's scattered records.
Navina's AI turns fragmented patient data (records, claims, labs) into a concise picture before each appointment and flags care gaps and diagnoses that should be documented, which matters for value-based care contracts.
It works with US primary care groups and health systems.
Predicts how a clinical trial will turn out before the drug company runs it.
QuantHealth trains AI on hundreds of millions of patient records to simulate trial outcomes, helping pharmaceutical companies design studies that are more likely to succeed.
It raised a $45 million Series B in August 2026.
An arm-worn device that treats migraine attacks through the skin.
Theranica's Nerivio uses remote electrical neuromodulation, controlled from a phone, to treat migraine without medication. It is FDA-cleared for adults and adolescents.
It is one of the more commercially established Israeli digital therapeutics companies.
Lets clinicians without specialist training capture diagnostic heart scans.
UltraSight's software guides the user in real time to capture usable cardiac ultrasound images, widening who can perform heart scans in clinics and remote settings.
It raised $24 million in September 2026.
Pairs pharmaceuticals with digital interventions to make them work better.
Remepy develops what it calls hybrid medicines: drugs combined with cognitive, psychological and motor exercises delivered digitally, starting with neurological conditions such as Parkinson's disease.
It raised a $36 million Series A in August 2026 and was named one of Qumra Capital's growth companies of 2026.
Aidoc is the largest Israeli medical AI company, with its software running in well over a thousand hospitals and a $150 million round in 2026. Among device companies, Insightec, the focused ultrasound company valued at over $1 billion, is the most established.
Israel's HMOs (Clalit, Maccabi, Meuhedet and Leumit) have kept digital records for most of the population for decades, giving researchers and startups unusually rich data. Add top medical research at the Technion, Weizmann Institute and Hebrew University, and an engineering workforce trained in imaging and signal processing, and medical AI becomes a natural fit.
Medtronic bought AI cardiology company CathWorks for $585 million (up to $1 billion with milestones), Olympus bought BioProtect, Artivion bought Endospan and Guardant Health bought MetaSight. Sight Diagnostics, despite raising $124 million, laid off its staff in April 2026.
Many are. The companies on this list sell under FDA clearance or approval for their core products, and most build for the US market first because it is where reimbursement is decided. Always check the specific product's regulatory status for your country.
Tel Aviv, Herzliya and Netanya for software and digital health; Haifa and the nearby Tirat Carmel industrial area for devices, close to the Technion and Rambam hospital; and Jerusalem around Hadassah and Hebrew University.